The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 19, 2016

Filed:

Jan. 11, 2011
Applicants:

Alessandra Bartolozzi, Norwalk, CT (US);

Angela Berry, Gaylordsville, CT (US);

Doris Riether, Biberach an der Riss, DE;

Monika Ermann, Wantage, GB;

James Edward Jenkins, Hungerford, GB;

Innocent Mushi, Abingdon, GB;

Inventors:

Alessandra Bartolozzi, Norwalk, CT (US);

Angela Berry, Gaylordsville, CT (US);

Doris Riether, Biberach an der Riss, DE;

Monika Ermann, Wantage, GB;

James Edward Jenkins, Hungerford, GB;

Innocent Mushi, Abingdon, GB;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 317/06 (2006.01); A61K 31/165 (2006.01); C07C 323/41 (2006.01); C07C 317/44 (2006.01); C07D 211/54 (2006.01); C07D 213/40 (2006.01); C07D 261/08 (2006.01); C07D 265/30 (2006.01); C07D 295/185 (2006.01); C07D 295/205 (2006.01); C07D 309/04 (2006.01); C07D 333/20 (2006.01); C07D 333/38 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07C 323/41 (2013.01); C07C 317/44 (2013.01); C07D 211/54 (2013.01); C07D 213/40 (2013.01); C07D 261/08 (2013.01); C07D 265/30 (2013.01); C07D 295/185 (2013.01); C07D 295/205 (2013.01); C07D 309/04 (2013.01); C07D 333/20 (2013.01); C07D 333/38 (2013.01); C07D 413/12 (2013.01); C07C 2101/04 (2013.01); C07C 2101/08 (2013.01); C07C 2101/14 (2013.01); C07C 2101/18 (2013.01);
Abstract

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.


Find Patent Forward Citations

Loading…